12 - 15 November 2015 Barcelona, Spain
![]() |
![]() |
![]() |
![]() |
6-P | The 4Kscore test predicts upgrading at prostatectomy among men with low-grade prostate cancer on prostate biopsy | Alberto Briganti | ![]() |
![]() |
|||
14-P | External radiation-therapy versus brachytherapy in low risk prostate cancer. RECAP-database analysis | Gustavo Ossola Lentati | ![]() |
![]() |
|||
24-P | Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients treated with radical prostatectomy | Arnau Serra Deola | ![]() |
![]() |
|||
25-P | Prospective evaluation on the outcome of inclusion of a multiparamentric MRI scan In MRI nave patients with low risk prostate cancer, already established on active surveillance | Thiru Suntharasivam | ![]() |
![]() |
|||
30-P | Erectile dysfunction a post-open radical prostatectomy. Prospective analysis of results. | Virginia Del Rosario Rodríguez | ![]() |
![]() |
|||
43-P | Accuracy of kallikrein testing (4K) in prostate cancer detection and grading. A preliminary prospective study | Francisco Clar | ![]() |
![]() |
|||
46-P | A Phase 3 study of enzalutamide in non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC) patients | Heather Sylvestro | ![]() |
![]() |
|||
47-P | Penile metastasis: A rare presentation of prostate cancer | Pedro Oliveira | ![]() |
![]() |
|||
52-P | Efficacy of abiraterone acetate in chemotherapy-naive patients with mCRPC presenting with visceral disease | Marina Mencinger | ![]() |
![]() |
|||
54-P | Survival after biochemical failure in prostate cancer: Recap database outcomes | Carmen González-San Segundo | ![]() |
![]() |
|||
60-P | How bad is the outcome of node positive prostate cancer patients: A matched case analysis between N and N0 prostate cancer patients | Valérie Fonteyne | ![]() |
![]() |
|||
78-P | Variation in prescription rate of the first post-docetaxel treatment and overall survival among patients with mCPRC in the CAstration-resistant Prostate cancer RegIstry (CAPRI): An observational study in the Netherlands | Hans Westgeest | ![]() |
![]() |
|||
84-P | Docetaxel treatment in castration-resistant prostate cancer (CRPC) clinical trials compared to standard care: Treatment duration and overall survival (OS) in CAPRI: An observational study in the Netherlands | Hans Westgeest | ![]() |
![]() |
|||
86-P | An audit and indirect comparison of the use of Cabazitaxel (CBZ) for the treatment of metastatic Castrate Resistant Prostate Cancer (mCRPC) progressing after docetaxel compared to previous experience with ECarboF | Mark Linch | ![]() |
![]() |
|||
95-P | Preferences for the management of androgen deprivation-induced osteoporosis and metabolic syndrome in prostate cancer patients: A European web-based survey | Piet Ost | ![]() |
![]() |
|||
96-P | Standard practice compared to evidence based strategies for the management of androgen deprivation-induced side effects in prostate cancer patients: A European web-based survey | Piet Ost | ![]() |
![]() |
|||
98-P | Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumour recurrence | Koji Izumi | ![]() |
![]() |
|||
104-P | Urothelial bladder pTx tumours. How to predict positivity of the immediate second TUR | Ignacio Arroyo Soto | ![]() |
![]() |
|||
108-P | Urinary exosomes: Promising biomarkers for urothelial bladder cancer | Renan Javier Otta Oshiro | ![]() |
![]() |
|||
122-P | A comparison of the efficacy of neoadjuvant versus adjuvant chemotherapy in the treatment of locally advanced bladder cancer | Tanja Ovcaricek | ![]() |
![]() |
|||
145-P | Ex vivo MRI as a tool to assess surgical margins directly following partial nephrectomy. | Tim van Oostenbrugge | ![]() |
![]() |
|||
149-P | Ablative treatment for small renal solid masses through cryotherapy and radiofrecuency: Efficacy and safety | DAVID CARRACEDO | ![]() |
![]() |
|||
153-P | Outcomes of conservative treatment of upper urinary tract carcinoma after a long term follow-up | Andrea Orosa Andrada | ![]() |
![]() |
|||
159-P | Small lung nodules at diagnosis should not automatically be considered metastatic renal cancer | Philippa Jefferson | ![]() |
![]() |
12 - 15 November 2015 Barcelona, Spain
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|